{"id":868604,"date":"2025-07-10T16:32:31","date_gmt":"2025-07-10T20:32:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/"},"modified":"2025-07-10T16:32:31","modified_gmt":"2025-07-10T20:32:31","slug":"class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/","title":{"rendered":"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">PHILADELPHIA<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">July 10, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4466002-1&amp;h=2914746881&amp;u=https%3A%2F%2Fbergermontague.com%2F&amp;a=Berger+Montague\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Berger Montague<\/span><\/a>, a national securities litigation law firm, is investigating potential securities <span>fraud<\/span> claims against <b>Hims &amp; Hers Health Inc.<\/b> (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) (<b>NYSE: HIMS<\/b>).<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg\" title=\"A national class action and commercial litigation law firm with nationally known attorneys highly sought after for their legal skills. (PRNewsFoto\/Berger Montague)\" alt=\"A national class action and commercial litigation law firm with nationally known attorneys highly sought after for their legal skills. (PRNewsFoto\/Berger Montague)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b><br \/>\n          <i>Investor Deadline:<\/i><br \/>\n        <\/b><br \/>\n        <i>\u00a0Investors who purchased or acquired Hims &amp; Hers securities between <b><span class=\"xn-chron\">April 29, 2025<\/span> and <span class=\"xn-chron\">June 22, 2025<\/span><\/b> (the &#8220;Class Period&#8221;) may, no later than <b><span class=\"xn-chron\">August 25, 2025<\/span><\/b>, seek to be appointed as a lead plaintiff representative of the class. To learn your rights,<\/i>\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4466002-1&amp;h=1016926334&amp;u=https%3A%2F%2Finvestigations.bergermontague.com%2Fhims-hers%2F&amp;a=CLICK+HERE\" target=\"_blank\" rel=\"nofollow\"><b>CLICK HERE<\/b><\/a><b>.<\/b><\/p>\n<p>On <span class=\"xn-chron\">June 23, 2025<\/span>, Novo Nordisk announced the termination of its partnership with Hims &amp; Hers, alleging that the company engaged in deceptive marketing and sold unapproved compounded versions of semaglutide. Following the announcement, shares of Hims &amp; Hers declined by over\u00a034% in intraday trading, reflecting investor concerns regarding regulatory compliance and reputational risks.<\/p>\n<p>This suit <span>alleges<\/span> throughout the Class Period, Hims &amp; Hers made materially false or misleading statements or omitted material information regarding the nature and regulatory status of its <span>GLP-1<\/span> offerings, the associated risks, and the partnership with Novo Nordisk. The firm is examining whether Hims &amp; Hers and certain executives violated federal securities laws by making false or misleading statements to investors.<\/p>\n<p>\n        <b><br \/>\n          <i>If you are a Hims &amp; Hers investor and would like to learn more about this action, <\/i><br \/>\n        <\/b><br \/>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4466002-1&amp;h=1016926334&amp;u=https%3A%2F%2Finvestigations.bergermontague.com%2Fhims-hers%2F&amp;a=CLICK+HERE\" target=\"_blank\" rel=\"nofollow\"><br \/>\n          <b><br \/>\n            <i>CLICK HERE<\/i><br \/>\n          <\/b><br \/>\n        <\/a>\u00a0<b><i>or please contact <span class=\"xn-person\">Berger Montague<\/span>: <span class=\"xn-person\">Andrew Abramowitz<\/span> at <\/i><\/b><a href=\"mailto:aabramowitz@bergermontague.com\" target=\"_blank\" rel=\"nofollow\"><b><i>aabramowitz@bergermontague.com<\/i><\/b><\/a><b><i>\u00a0or (215) 875-3015, or <span class=\"xn-person\">Caitlin Adorni<\/span> at <\/i><\/b><a href=\"mailto:cadorni@bergermontague.com\" target=\"_blank\" rel=\"nofollow\"><b><i>cadorni@bergermontague.com<\/i><\/b><\/a><b><i>\u00a0or (267)764-4865.<\/i><\/b><\/p>\n<p>\n        <b>About <span class=\"xn-person\">Berger Montague<\/span><br \/><\/b><br \/>\n        <span class=\"xn-person\">Berger Montague<\/span>, with offices in <span class=\"xn-location\">Philadelphia<\/span>, <span class=\"xn-location\">Minneapolis<\/span>, <span class=\"xn-location\">Delaware<\/span>, <span class=\"xn-location\">Washington, D.C.<\/span>, <span class=\"xn-location\">San Diego<\/span>, <span class=\"xn-location\">San Francisco<\/span> and <span class=\"xn-location\">Chicago<\/span>, has been a pioneer in <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4466002-1&amp;h=3139700982&amp;u=https%3A%2F%2Fbergermontague.com%2Fsecurities%2F&amp;a=securities+class+action+litigation\" target=\"_blank\" rel=\"nofollow\">securities class action litigation<\/a>\u00a0since its founding in 1970. <span class=\"xn-person\">Berger Montague<\/span> has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout <span class=\"xn-location\">the United States<\/span>.<\/p>\n<p>\n        <b>For more information or to discuss your rights, please contact:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Andrew Abramowitz<\/span>, Senior Counsel<br \/><span class=\"xn-person\">Berger Montague<\/span><br \/>(215) 875-3015<br \/><a href=\"mailto:aabramowitz@bergermontague.com\" rel=\"nofollow\">aabramowitz@bergermontague.com<\/a><\/p>\n<p>\n        <span class=\"xn-person\">Caitlin Adorni<\/span><br \/>\n        <br \/>\n        <span class=\"xn-person\">Berger Montague<\/span><br \/>\n        <br \/>(267) 764-4865<br \/><a href=\"mailto:cadorni@bergermontague.com\" rel=\"nofollow\">cadorni@bergermontague.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DC27927&amp;sd=2025-07-10\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/class-action-reminder-berger-montague-advises-hims--hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025-302502370.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/class-action-reminder-berger-montague-advises-hims&#8211;hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025-302502370.html<\/a><\/p>\n<p>SOURCE  <span class=\"xn-person\">Berger Montague<\/span><\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DC27927&amp;Transmission_Id=202507101606PR_NEWS_USPR_____DC27927&amp;DateId=20250710\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire PHILADELPHIA , July 10, 2025 \/PRNewswire\/ &#8212;\u00a0Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims &amp; Hers Health Inc. (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) (NYSE: HIMS). Investor Deadline: \u00a0Investors who purchased or acquired Hims &amp; Hers securities between April 29, 2025 and June 22, 2025 (the &#8220;Class Period&#8221;) may, no later than August 25, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights,\u00a0CLICK HERE. On June 23, 2025, Novo Nordisk announced the termination of its partnership with Hims &amp; Hers, alleging that the company engaged in deceptive marketing and sold unapproved compounded versions of semaglutide. Following the announcement, shares of Hims &amp; &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-868604","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire PHILADELPHIA , July 10, 2025 \/PRNewswire\/ &#8212;\u00a0Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims &amp; Hers Health Inc. (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) (NYSE: HIMS). Investor Deadline: \u00a0Investors who purchased or acquired Hims &amp; Hers securities between April 29, 2025 and June 22, 2025 (the &#8220;Class Period&#8221;) may, no later than August 25, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights,\u00a0CLICK HERE. On June 23, 2025, Novo Nordisk announced the termination of its partnership with Hims &amp; Hers, alleging that the company engaged in deceptive marketing and sold unapproved compounded versions of semaglutide. Following the announcement, shares of Hims &amp; &hellip; Continue reading &quot;CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-10T20:32:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025\",\"datePublished\":\"2025-07-10T20:32:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/\"},\"wordCount\":355,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/\",\"name\":\"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"datePublished\":\"2025-07-10T20:32:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/232479\\\/berger_montague.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/","og_locale":"en_US","og_type":"article","og_title":"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025 - Market Newsdesk","og_description":"PR Newswire PHILADELPHIA , July 10, 2025 \/PRNewswire\/ &#8212;\u00a0Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims &amp; Hers Health Inc. (&#8220;Hims &amp; Hers&#8221; or the &#8220;Company&#8221;) (NYSE: HIMS). Investor Deadline: \u00a0Investors who purchased or acquired Hims &amp; Hers securities between April 29, 2025 and June 22, 2025 (the &#8220;Class Period&#8221;) may, no later than August 25, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights,\u00a0CLICK HERE. On June 23, 2025, Novo Nordisk announced the termination of its partnership with Hims &amp; Hers, alleging that the company engaged in deceptive marketing and sold unapproved compounded versions of semaglutide. Following the announcement, shares of Hims &amp; &hellip; Continue reading \"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-10T20:32:31+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025","datePublished":"2025-07-10T20:32:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/"},"wordCount":355,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/","name":"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","datePublished":"2025-07-10T20:32:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/232479\/berger_montague.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/class-action-reminder-berger-montague-advises-hims-hers-health-inc-nyse-hims-investors-to-inquire-about-a-securities-fraud-lawsuit-by-august-25-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CLASS ACTION REMINDER: Berger Montague Advises Hims &amp; Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Lawsuit by August 25, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/868604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=868604"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/868604\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=868604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=868604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=868604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}